Correlation Between Equillium and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Equillium and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Lumos Pharma, you can compare the effects of market volatilities on Equillium and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Lumos Pharma.
Diversification Opportunities for Equillium and Lumos Pharma
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Equillium and Lumos is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Equillium i.e., Equillium and Lumos Pharma go up and down completely randomly.
Pair Corralation between Equillium and Lumos Pharma
Allowing for the 90-day total investment horizon Equillium is expected to generate 1.52 times more return on investment than Lumos Pharma. However, Equillium is 1.52 times more volatile than Lumos Pharma. It trades about 0.03 of its potential returns per unit of risk. Lumos Pharma is currently generating about 0.04 per unit of risk. If you would invest 83.00 in Equillium on September 12, 2024 and sell it today you would lose (13.00) from holding Equillium or give up 15.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Equillium vs. Lumos Pharma
Performance |
Timeline |
Equillium |
Lumos Pharma |
Equillium and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Equillium and Lumos Pharma
The main advantage of trading using opposite Equillium and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Lumos Pharma vs. Equillium | Lumos Pharma vs. DiaMedica Therapeutics | Lumos Pharma vs. Valneva SE ADR | Lumos Pharma vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Transaction History View history of all your transactions and understand their impact on performance |